Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Vitrakvi for Solid Tumors with NTRK Gene Fusions

americanpharmaceuticalreviewNovember 29, 2018

Tag: FDA , Vitrakvi , NTRK , Gene Fusions

PharmaSources Customer Service